Overview
Anna Belcheva is an Oncologist in Houston, Texas. Dr. Belcheva is highly rated in 11 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Childhood Iron Deficiency Anemia, and Inflammatory Breast Cancer. Dr. Belcheva is currently accepting new patients.
Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
13215 Dotson Rd Ste 300, Houston, TX 77070
506 Graham Dr Ste 150, Tomball, TX 77375
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Office
Hagop Kantarjian is an Oncologist in Houston, Texas. Dr. Kantarjian is highly rated in 47 conditions, according to our data. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of Texas MD Anderson Cancer Center
Naval Daver is an Oncologist in Houston, Texas. Dr. Daver is highly rated in 40 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
UT MD Anderson Cancer Center
Neeta Somaiah is an Oncologist in Houston, Texas. Dr. Somaiah is highly rated in 28 conditions, according to our data. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Hepato-Pancreato-Biliary Surgery.
Frequently Asked Questions about Dr. Anna Belcheva
Is Dr. Anna Belcheva a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anna Belcheva is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Anna Belcheva specialize in?
While Dr. Anna Belcheva is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Childhood Iron Deficiency Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Anna Belcheva participate in research or clinical trials?
Yes. Dr. Anna Belcheva has published 5 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Anna Belcheva's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Anna Belcheva accept my insurance?
Dr. Anna Belcheva accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Belcheva isDistinguished. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Belcheva isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Paget Disease of the BreastDr. Belcheva isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acute Mountain SicknessDr. Belcheva isAdvanced. Learn about Acute Mountain Sickness.
- AngiosarcomaDr. Belcheva isAdvanced. Learn about Angiosarcoma.
- Classical Hodgkin LymphomaDr. Belcheva isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Belcheva isAdvanced. Learn about Hodgkin Lymphoma.
- Inflammatory Breast CancerDr. Belcheva isAdvanced. Learn about Inflammatory Breast Cancer.
- Iron Deficiency AnemiaDr. Belcheva isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Adult Soft Tissue SarcomaDr. Belcheva isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Belcheva isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Belcheva isExperienced. Learn about Anemia.
- Appendix CancerDr. Belcheva isExperienced. Learn about Appendix Cancer.
- Bladder CancerDr. Belcheva isExperienced. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Belcheva isExperienced. Learn about Chromophobe Renal Cell Carcinoma.